Eudaimonia Partners, LLC Myriad Genetics Inc Transaction History

Eudaimonia Partners, LLC

  • $416 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$22.67 - $28.01 $152,614 - $188,563
-6,732 Closed
0 $0
Q3 2021

Oct 25, 2021
BUY
$29.97 - $36.66 $201,758 - $246,795
6,732 New
6,732 $217,000
Q2 2021

Aug 13, 2021
SELL
$25.39 - $32.61 $13,228 - $16,989
-521 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$19.92 - $31.6 $10,378 - $16,463
521 New
521 $16,000

Others Institutions Holding MYGN

# of Institutions
238
Shares Held
92.7M
Call Options Held
117K
Put Options Held
113K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.77B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Eudaimonia Partners, LLC Portfolio

Follow Eudaimonia Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email